文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

矿物粉尘诱导基因通过调节 EGFR 和 HIF-1α 信号通路来调节 VEGF-A/C/D 的表达,从而调控肺腺癌中的血管生成和淋巴管生成。

The mineral dust-induced gene, , regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling.

机构信息

Department of Pulmonary Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.

出版信息

Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8011. Epub 2021 Mar 24.


DOI:10.3892/or.2021.8011
PMID:33760153
Abstract

Mineral dust‑induced gene () is a novel lung cancer‑related oncogene. The aim of this study was to explore the effects of mdig on angiogenesis and lymphangiogenesis by vascular endothelial growth factor (VEGF) in lung adenocarcinoma. mdig‑overexpressing A549, H1299 and 293T cells, mdig‑silenced A549, human umbilical vein endothelial cells (HUVECs) and human lymphatic endothelial cells (HLECs) were cultured under normoxic and hypoxic conditions. Protein expression levels of mdig, epidermal growth factor receptor (EGFR), phospho(p)‑EGFR Tyr1068, hypoxia‑inducible factor‑1α (HIF‑1α), VEGF‑A/C/D and VEGF‑R1/R2/R3 were assessed using western blotting. mRNA expression levels of mdig, EGFR and HIF‑1α were measured using RT‑qPCR. Tube formation and xenograft tumor experiments were performed to examine the mechanism of mdig in angiogenesis and lymphangiogenesis. Protein expression levels of EGFR, HIF‑1α and VEGF‑A/C/D were significantly upregulated in cells cultured under hypoxic conditions compared with those cultured under normoxic conditions, whereas the levels of mdig were decreased. Protein expression levels of EGFR, p‑EGFR and VEGF‑A/R1/R2 were significantly increased in the mdig‑overexpressing cells, whereas the levels of HIF‑1α and VEGF‑C/D/R3 were decreased compared with those in control cells, all of which were reversed in mdig‑silenced cells. Tumor volumes and density of angiogenesis in the mdig‑overexpressing group were significantly increased compared with those in the control group, whereas the density of lymphangiogenesis was decreased. No tumors formed in the mdig‑silenced group after 3 weeks of assessment . Protein expression levels of EGFR, p‑EGFR, VEGF‑A and angiogenesis density were significantly reduced in the mdig‑overexpressing cells treated with an EGFR inhibitor, whereas the levels of HIF‑1α, VEGF‑C/D and the lymphangiogenesis density were significantly increased in mdig‑overexpressing cells treated with a HIF‑1α agonist. All changes in protein expression were reversed in EGFR agonist and HIF‑1α inhibitor treated mdig‑silenced cells. In conclusion, mdig is an oxygen‑sensitive protein that promotes tumor growth and angiogenesis by activating the EGFR/p‑EGFR/VEGF‑A/VEGF‑R1/R2 pathway and inhibits lymphangiogenesis by blocking the HIF‑1α/VEGF‑C/D/VEGF‑R3 pathway.

摘要

矿物尘埃诱导基因()是一种新的肺癌相关癌基因。本研究旨在探讨在肺腺癌中通过血管内皮生长因子(VEGF)介导的mdig 对血管生成和淋巴管生成的影响。在常氧和低氧条件下培养mdig 过表达的 A549、H1299 和 293T 细胞、mdig 沉默的 A549、人脐静脉内皮细胞(HUVECs)和人淋巴管内皮细胞(HLECs)。采用 Western blot 检测 mdig、表皮生长因子受体(EGFR)、磷酸化(p)-EGFR Tyr1068、缺氧诱导因子-1α(HIF-1α)、VEGF-A/C/D 和 VEGF-R1/R2/R3 的蛋白表达水平。采用 RT-qPCR 检测 mdig、EGFR 和 HIF-1α 的 mRNA 表达水平。进行管形成和异种移植肿瘤实验,以研究 mdig 在血管生成和淋巴管生成中的作用机制。与常氧条件下培养的细胞相比,低氧条件下培养的细胞中 mdig 的蛋白表达水平显著下调,而 EGFR、HIF-1α 和 VEGF-A/C/D 的蛋白表达水平显著上调。与对照组相比,mdig 过表达细胞中 EGFR、p-EGFR 和 VEGF-A/R1/R2 的蛋白表达水平显著增加,而 HIF-1α 和 VEGF-C/D/R3 的蛋白表达水平显著降低,这些变化在 mdig 沉默细胞中均被逆转。mdig 过表达组的肿瘤体积和血管生成密度明显高于对照组,而淋巴管生成密度则降低。在 3 周的评估后,mdig 沉默组没有形成肿瘤。在 mdig 过表达细胞中用 EGFR 抑制剂处理后,EGFR、p-EGFR、VEGF-A 和血管生成密度的蛋白表达水平显著降低,而在用 HIF-1α 激动剂处理的 mdig 过表达细胞中,HIF-1α、VEGF-C/D 和淋巴管生成密度的蛋白表达水平显著增加。在 EGFR 激动剂和 HIF-1α 抑制剂处理的 mdig 沉默细胞中,所有蛋白表达的变化均被逆转。总之,mdig 是一种氧敏感蛋白,通过激活 EGFR/p-EGFR/VEGF-A/VEGF-R1/R2 通路促进肿瘤生长和血管生成,通过阻断 HIF-1α/VEGF-C/D/VEGF-R3 通路抑制淋巴管生成。

相似文献

[1]
The mineral dust-induced gene, , regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling.

Oncol Rep. 2021-5

[2]
PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.

Tissue Cell. 2022-12

[3]
Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.

Oncogene. 2018-1-25

[4]
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.

IUBMB Life. 2018-1

[5]
Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.

Oncotarget. 2017-1-31

[6]
TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.

Oncol Rep. 2019-2-21

[7]
Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.

PLoS One. 2014-8-27

[8]
Mdig promotes oncogenic gene expression through antagonizing repressive histone methylation markers.

Theranostics. 2020

[9]
Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.

J Cell Biochem. 2018-6-15

[10]
Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.

J Biol Chem. 2016-7-29

引用本文的文献

[1]
Deciphering the angiogenic potential of Zhishi Xiebai Guizhi decoction in coronary heart disease: an in-depth network pharmacology and experimental investigation.

Sci Rep. 2025-7-2

[2]
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease.

J Clin Exp Hematop. 2024-12-25

[3]
Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy.

Clin Transl Oncol. 2025-5

[4]
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors.

J Cancer Res Clin Oncol. 2024-4-30

[5]
Advances in lymphatic metastasis of non-small cell lung cancer.

Cell Commun Signal. 2024-4-2

[6]
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.

Front Oncol. 2023-10-3

[7]
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.

Target Oncol. 2023-3

[8]
MDIG, a 2‑oxoglutarate‑dependent oxygenase, acts as an oncogene and predicts the prognosis of multiple types of cancer.

Int J Oncol. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索